Soru

Zorluk: OrtaPreventive Care and Immunizations

A 4-year-old girl is brought to the pediatric clinic for a well-child examination before starting preschool. She has a medical history of end-stage renal disease secondary to severe reflux nephropathy and underwent a deceased-donor kidney transplantation one year ago. Her daily medication regimen includes tacrolimus, mycophenolate mofetil, and low-dose prednisone. During the interview, the mother expresses concern that her daughter might have a developmental delay because she cannot yet skip across the room or tie her own shoelaces. On examination, the girl hops confidently on one foot, clearly copies a cross on a piece of paper, and speaks in fully intelligible sentences. The mother notes she engages frequently in cooperative play with her older brother. Physical examination is unremarkable, with well-healed surgical scars and normal vital signs. A review of her state immunization registry indicates she received all routine childhood vaccinations up to 24 months of age. The mother asks which vaccines her daughter should receive today and if a developmental referral is warranted. Which of the following is the most appropriate management for this patient?

  1. Give diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines, and validate that her current skills are age-appropriateCevap
  2. B
    Give diphtheria-tetanus-acellular pertussis, inactivated poliovirus, measles-mumps-rubella, and varicella vaccines, and validate that her current skills are age-appropriate
  3. C
    Give diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines, and arrange a multidisciplinary assessment for developmental delay
  4. D
    Give diphtheria-tetanus-acellular pertussis, inactivated poliovirus, measles-mumps-rubella, and varicella vaccines, and arrange a multidisciplinary assessment for developmental delay
  5. E
    Postpone all childhood immunizations while the patient remains on anti-rejection medications, and validate that her current skills are age-appropriate

Cevap

Give diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines, and validate that her current skills are age-appropriate.
This 4-year-old patient is on a regimen of tacrolimus, mycophenolate mofetil, and prednisone following a kidney transplant, placing her in a state of severe cellular immunosuppression. In such patients, live-attenuated vaccines (e.g., measles-mumps-rubella [MMR], varicella, intranasal influenza) are strictly contraindicated due to the high risk of uncontrolled vaccine-strain viral replication and disseminated disease. However, inactivated vaccines (e.g., diphtheria-tetanus-acellular pertussis [DTaP], inactivated poliovirus [IPV], intramuscular influenza) are safe, do not cause infectious disease, and should be administered according to the routine schedule to provide necessary protection, even if the resulting immune response may be blunted compared to healthy children. Regarding her neurodevelopment, she has successfully met the milestones expected for a 4-year-old, which include hopping on one foot, copying a cross, cooperative play, and 100% speech intelligibility. Her inability to skip or tie shoelaces is entirely normal, as these specific gross and fine motor skills are typically mastered by age 5. Therefore, she requires only age-appropriate inactivated vaccines and parental reassurance.

Adım Adım Çözüm

1
Evaluate the patient's developmental milestones to determine if a delay is present.
The patient can hop on one foot, copy a cross, and engage in cooperative play, which perfectly align with 4-year-old milestones. Skipping and tying shoelaces are 5-year-old milestones.
Accurately identifying normal development is necessary to decide between parental reassurance and formal developmental referral.
2
Assess the patient's immunization needs and immune status.
The patient is due for her 4-6 year pre-kindergarten booster vaccines (DTaP, IPV, MMR, Varicella). However, she is on a potent immunosuppressive regimen (tacrolimus, mycophenolate, prednisone) for a kidney transplant.
Vaccine safety profiles differ based on host immune competence.
3
Formulate the most appropriate management plan based on the assessments.
Administer the inactivated vaccines (DTaP, IPV) safely, strictly withhold the live-attenuated vaccines (MMR, Varicella), and provide reassurance that her development is completely on track.
Live vaccines carry a risk of disseminated vaccine-strain infection in immunocompromised patients, but inactivated vaccines do not and remain highly recommended.

Anahtar Kavram

Immunization guidelines in immunocompromised pediatric patients and normal 4-year-old developmental milestones.
Bu soruyu puanla